Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 10,365 | 5,657 | 6,231 | 5,907 | 5,706 |
| Operating Income | -10,365 | -5,657 | -6,231 | -5,907 | -5,706 |
| Other Income | 1,035 | 841 | -574 | 287 | 1,286 |
| Pre-tax Income | -9,330 | -4,816 | -6,805 | -5,620 | -4,420 |
| Net Income Continuous | -9,330 | -4,816 | -6,805 | -5,620 | -4,420 |
| Net Income | $-9,330 | $-4,816 | $-6,805 | $-5,620 | $-4,420 |
| EPS Basic Total Ops | -0.13 | -0.07 | -0.10 | -0.09 | -0.07 |
| EPS Basic Continuous Ops | -0.13 | -0.07 | -0.10 | -0.09 | -0.07 |
| EPS Diluted Total Ops | -0.13 | -0.07 | -0.10 | -0.09 | -0.07 |
| EPS Diluted Continuous Ops | -0.13 | -0.07 | -0.10 | -0.09 | -0.07 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.07 | -0.10 | N/A | N/A |
| EBITDA(a) | $-10,217 | $-5,612 | $-6,185 | $-5,858 | $-5,657 |